Biogen Idec will get early look at gene data from ALS collaboration
This article was originally published in Scrip
Executive Summary
Biogen Idec will get a sneak peek at data from its project with two research institutions and several scientists to sequence the genomes of up to 1,000 amyotrophic lateral sclerosis (ALS) patients to inform its search for new drug therapies to treat the neurodegenerative disorder.